Medicines optimisation · September 2026

Medicines optimisation in Thames Valley ICB

NHS Thames Valley Integrated Care Board has 62 PCNs and 2,474,478 registered patients. These are its headline figures for September 2026 from NHSBSA’s prescribing data.

Get a delivery plan

Price-per-unit savings
£594,319in one month
Per 1,000 registered patients
£240England: £257
DOAC prescriptions that were best value
84%England: 83%
Ghost generics
£60,066at 60 practices, part of the price-per-unit savings

Price per unit

In September 2026, practices in Thames Valley could have saved £594,319 by paying what the cheapest tenth of practices in England paid for the same medicines. That is £240 for every 1,000 registered patients, the 23rd highest of England’s 36 ICBs.

Best value DOACs

49,793 of 59,190 DOAC prescriptions (84%) were generic apixaban or rivaroxaban tablets, NHS England’s joint best value DOACs. They cost £2.42 a prescription. The other 9,397 cost £45.05 a prescription. Changing anyone’s anticoagulant is a clinical decision made with the patient after a review, so we show the difference in cost, not a saving.

Ghost generics

60 practices prescribed generic medicines as one maker’s product instead of by their generic name, with £60,066 of price-per-unit savings on them in the month. This is part of the price-per-unit savings above, not extra to them.

Project work

Get a delivery plan for Thames Valley

You know the data. The hard part is the time to do the work, practice by practice. Tell us the project and we’ll send a plan:

  • which practices to start with, and why
  • the work your prescribing scheme already pays practices for
  • how many pharmacist sessions it needs

Then we place clinical pharmacists to do it, for as long as the project needs.

The project (optional, pick any)
When would it start? (optional)

Your details go only to our clinical team. Please don’t include any patient details. Privacy notice.

How we work these out

Every figure is one month, September 2026, from NHSBSA’s English Prescribing Dataset for GP practices, as the data gives it: no saving is estimated or scaled up to a year.

  • Price-per-unit savings are what each practice would have saved if it had paid what the cheapest tenth of practices in England paid per unit for the same medicine, counted where the practice would save at least £10 on that medicine in the month. This is OpenPrescribing’s price-per-unit method. Some savings can’t be made, for example where a medicine is short or on price concession.
  • Ghost generics are generic medicines prescribed as one maker’s product instead of by their generic name, where England mostly prescribes the generic. They are part of the price-per-unit savings, not extra to them.
  • Best value DOACs are generic apixaban and generic rivaroxaban tablets, NHS England’s joint best value direct-acting oral anticoagulants. We show the cost per prescription of each group, not a saving: changing anyone’s anticoagulant is a clinical decision made with the patient after a review.

Sources

Contains public sector information licensed under the Open Government Licence v3.0.

Every ICB in England